Castrate-Resistant Prostate Cancer Market: An In-Depth Analysis of...

σε πρόσθεσε στο Health

2024-09-23 06:15:34 - Μετάφραση -

Castrate-Resistant Prostate Cancer Market: An In-Depth Analysis of Growth, Trends, and Innovation 2032

Castrate-resistant prostate cancer (CRPC) represents the most aggressive form of prostate cancer, one that continues to progress despite androgen-deprivation therapy (ADT), which is the primary treatment for early-stage prostate cancer. The global market for CRPC therapies was valued at USD 11.19 billion in 2023 and is projected to reach USD 23.50 billion by 2032, growing at a compound annual...

0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση